Logo image of ALPAT.PA

PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis

EPA:ALPAT - Euronext Paris - Matif - FR0010785790 - Common Stock - Currency: EUR

10.5  -0.1 (-0.94%)

Fundamental Rating

4

ALPAT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 72 industry peers in the Biotechnology industry. While ALPAT is still in line with the averages on profitability rating, there are concerns on its financial health. ALPAT is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

ALPAT had positive earnings in the past year.
ALPAT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALPAT reported negative operating cash flow in multiple years.
ALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFALPAT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

ALPAT has a Return On Assets of 7.61%. This is amongst the best in the industry. ALPAT outperforms 93.06% of its industry peers.
The Return On Equity of ALPAT (13.93%) is better than 88.89% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.47%, ALPAT belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
Industry RankSector Rank
ROA 7.61%
ROE 13.93%
ROIC 2.47%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALPAT.PA Yearly ROA, ROE, ROICALPAT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

With an excellent Profit Margin value of 43.01%, ALPAT belongs to the best of the industry, outperforming 98.61% of the companies in the same industry.
In the last couple of years the Profit Margin of ALPAT has declined.
ALPAT has a Operating Margin of 14.45%. This is amongst the best in the industry. ALPAT outperforms 84.72% of its industry peers.
ALPAT has a Gross Margin of 110.03%. This is amongst the best in the industry. ALPAT outperforms 97.22% of its industry peers.
ALPAT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.45%
PM (TTM) 43.01%
GM 110.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-42.62%
GM growth 3Y-2.47%
GM growth 5Y-2.57%
ALPAT.PA Yearly Profit, Operating, Gross MarginsALPAT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

ALPAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for ALPAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALPAT.PA Yearly Shares OutstandingALPAT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M
ALPAT.PA Yearly Total Debt VS Total AssetsALPAT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

ALPAT has an Altman-Z score of 0.80. This is a bad value and indicates that ALPAT is not financially healthy and even has some risk of bankruptcy.
ALPAT has a Altman-Z score (0.80) which is in line with its industry peers.
ALPAT has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
ALPAT's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. ALPAT outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 0.8
ROIC/WACC0.32
WACC7.7%
ALPAT.PA Yearly LT Debt VS Equity VS FCFALPAT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M 10M

2.3 Liquidity

ALPAT has a Current Ratio of 0.87. This is a bad value and indicates that ALPAT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALPAT (0.87) is worse than 72.22% of its industry peers.
A Quick Ratio of 0.55 indicates that ALPAT may have some problems paying its short term obligations.
ALPAT's Quick ratio of 0.55 is on the low side compared to the rest of the industry. ALPAT is outperformed by 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.55
ALPAT.PA Yearly Current Assets VS Current LiabilitesALPAT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

8

3. Growth

3.1 Past

ALPAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 404.24%, which is quite impressive.
The earnings per share for ALPAT have been decreasing by -39.38% on average. This is quite bad
Looking at the last year, ALPAT shows a very strong growth in Revenue. The Revenue has grown by 46.37%.
Measured over the past years, ALPAT shows a quite strong growth in Revenue. The Revenue has been growing by 8.05% on average per year.
EPS 1Y (TTM)404.24%
EPS 3YN/A
EPS 5Y-39.38%
EPS Q2Q%182.07%
Revenue 1Y (TTM)46.37%
Revenue growth 3Y10.21%
Revenue growth 5Y8.05%
Sales Q2Q%293.38%

3.2 Future

Based on estimates for the next years, ALPAT will show a very strong growth in Earnings Per Share. The EPS will grow by 42.66% on average per year.
ALPAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.56% yearly.
EPS Next Y-8.06%
EPS Next 2Y40.28%
EPS Next 3Y42.66%
EPS Next 5YN/A
Revenue Next Year-4.17%
Revenue Next 2Y4.08%
Revenue Next 3Y18.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALPAT.PA Yearly Revenue VS EstimatesALPAT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1M 2M 3M 4M
ALPAT.PA Yearly EPS VS EstimatesALPAT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.50, the valuation of ALPAT can be described as reasonable.
Based on the Price/Earnings ratio, ALPAT is valued cheaper than 94.44% of the companies in the same industry.
ALPAT is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
ALPAT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 10.5
Fwd PE N/A
ALPAT.PA Price Earnings VS Forward Price EarningsALPAT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than ALPAT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.57
ALPAT.PA Per share dataALPAT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ALPAT's earnings are expected to grow with 42.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y42.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALPAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLANT ADVANCED TECHNOLOGIES

EPA:ALPAT (3/7/2025, 7:00:00 PM)

10.5

-0.1 (-0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-01 2025-03-01/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners34.57%
Ins Owner ChangeN/A
Market Cap11.65M
Analysts84.44
Price Target11.73 (11.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.5
Fwd PE N/A
P/S 4.6
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 2.57
EV/EBITDA 15.57
EPS(TTM)1
EY9.52%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.28
BVpS7.04
TBVpS4.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.61%
ROE 13.93%
ROCE 3.43%
ROIC 2.47%
ROICexc 2.47%
ROICexgc 3.53%
OM 14.45%
PM (TTM) 43.01%
GM 110.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-42.62%
GM growth 3Y-2.47%
GM growth 5Y-2.57%
F-ScoreN/A
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA 3.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.55
Altman-Z 0.8
F-ScoreN/A
WACC7.7%
ROIC/WACC0.32
Cap/Depr(3y)113.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)54.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)404.24%
EPS 3YN/A
EPS 5Y-39.38%
EPS Q2Q%182.07%
EPS Next Y-8.06%
EPS Next 2Y40.28%
EPS Next 3Y42.66%
EPS Next 5YN/A
Revenue 1Y (TTM)46.37%
Revenue growth 3Y10.21%
Revenue growth 5Y8.05%
Sales Q2Q%293.38%
Revenue Next Year-4.17%
Revenue Next 2Y4.08%
Revenue Next 3Y18.56%
Revenue Next 5YN/A
EBIT growth 1Y126.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.94%
EBIT Next 3Y34.1%
EBIT Next 5YN/A
FCF growth 1Y191.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1442.12%
OCF growth 3Y186%
OCF growth 5YN/A